Mimedx (MDXG) Cash from Operations (2011 - 2026)

Mimedx has disclosed Cash from Operations across 16 years of filings, most recently posting -$10.0 million for Q2 2026.

• In Q2 2026, Cash from Operations fell 169.46% year-over-year to -$10.0 million; the TTM figure through Jun 2026 stood at $46.1 million (down 20.6% YoY), while the FY2025 annual figure was $74.0 million, up 10.24% from the prior year.
• Cash from Operations came in at -$10.0 million for Q2 2026 at Mimedx, down from $1.9 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $29.3 million in Q3 2025 to a low of -$10.2 million in Q1 2022.
• Average Cash from Operations over 5 years is $8.3 million, with a median of $8.0 million recorded in 2023.
• Year-over-year, Cash from Operations sank 287.93% in 2022 and jumped 1266.01% in 2023.
• Over 5 years, Cash from Operations stood at -$5.6 million in 2022, then jumped by 264.83% to $9.3 million in 2023, then surged by 102.6% to $18.8 million in 2024, then surged by 32.88% to $25.0 million in 2025, then plunged by 140.13% to -$10.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$10.0 million in Q2 2026, $1.9 million in Q1 2026, and $25.0 million in Q4 2025.